Expiring federal contract
75A50123C00036 — Siro Diagnostics, INC.
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Contract / PIID
- 75A50123C00036
- Incumbent
- Siro Diagnostics, INC.
- Incumbent UEI
- CM9UQ5VFMTZ3
- Current end date
- May 1, 2027
- Potential total value
- $28,341,000
- Obligated
- $28,341,000
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- Set-aside
- Full & Open
- Start date
- August 2, 2023
- Place of performance
- CA
- Award type
- DEFINITIVE CONTRACT
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND
Likely rebid window (estimate)
- Sources Sought / RFI: about May 2026 – Nov 2026 (6–12 months before the end date)
- RFP: about Jan 2027 – Mar 2027 (2–4 months before the end date)
Between the estimated Sources Sought and RFP windows.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: 1 recorded change to the end date, value or incumbent. Sign up to see each one.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325413)
- 75H71025P00975 — Becton, Dickinson And Company · ends November 30, 2026 · $103K
- 75H71226F28022 — Cepheid · ends January 11, 2027 · $460K
- 75N90026P00079 — Werfen USA LLC · ends January 31, 2027 · $170K
- 75H71226F28026 — Cepheid · ends February 7, 2027 · $272K
- 75H71226F28010 — Biomerieux INC · ends February 26, 2027 · $240K
- 75H70722P00094 — Cepheid · ends February 28, 2027 · $2.8M
- 75H70723F80016 — Abbott Laboratories INC. · ends February 28, 2027 · $310K
- 75H71025F80116 — Roche Diabetes Care INC · ends March 31, 2027 · $244K
- 75H71226F28027 — Cepheid · ends April 14, 2027 · $600K
- 75H70726F80013 — Fisher Scientific Company L.L.C. · ends April 30, 2027 · $610K